Answers are grounded in this paper and cite their sources.
Background: Corticosteroids may be temporarily effective for ulcerative colitis (UC), but long-term use increases the risk of adverse drug reactions.Objective: The goal of the study was to examine steroid use in remission induction therapy after diagnosis of UC.Study Design: A retrospective observational study using the Japan Medical Data Center (JMDC) Claims Database from January 2008 to December 2014.Setting: Clinics, university hospitals, and national/public hospitals.Intervention: Initiation of steroids after diagnosis of UC.Main outcome measures: Start time and annual rate of steroid use, and use during the first 6 months of remission induction therapy.Results: The subjects were 399 patients were newly diagnosed with UC in the study period. The rate of steroid use after diagnosis was 58.4% in 2009, and showed a significant decreasing trend yearly after 2010 (p ≤ 0.0001). Regarding the start time, 52.2% of patients began steroids within 60 days after diagnosis of UC. At 6 months after initiation, 23.7% continued to use steroids and 73.9% of these patients used high-dose steroids.Conclusion: In treatment of UC after diagnosis, many patients continue to use steroids for >6 months after initiation. Reduced use of steroids based on clinical practice guidelines for UC should be promoted.
No takes yet. Share an insight, caveat, or question.
Okayasu et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: